Leo Lens Pharma Excited to Have Its Lead Asset Ready for Human Clinical Evaluation
Patented product for the novel treatment of glaucoma is
Patented product for the novel treatment of glaucoma is
Accomplished Ophthalmic Executive to Lead Company in Its Next PhaseSAN
Leo Lens Pharma Strengthens its Pipeline with New IP
FOR IMMEDIATE RELEASELeo Lens Technology Selected as Finalist for Connect’s
Leo Lens was featured in a Member Spotlight article from
Leo Lens was selected from over 150 companies to be